| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |